Advertisement
Advertisement
CSTL
Castle Biosciences, Inc. Common Stock
39.76
USDSponsored
+0.37
+0.93%
Feb 02, 09:40 UTC -5
Open
CSTL Earnings Reports
Positive Surprise Ratio
CSTL beat 20 of 26 last estimates.
77%
Next Report
Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$78.64M
/-$0.31
Implied change from Q3 25 (Revenue/ EPS)
-5.30%
/+1450.00%
Implied change from Q4 24 (Revenue/ EPS)
-8.89%
/-193.94%
Castle Biosciences, Inc. Common Stock earnings per share and revenue
On Nov 03, 2025, CSTL reported earnings of -0.02 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 96.25% surprise. Revenue reached 83.04 million, compared to an expected 72.63 million, with a 14.33% difference. The market reacted with a +21.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 78.64 million USD, implying an increase of 1450.00% EPS, and decrease of -5.30% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
FAQ
What were Castle Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Castle Biosciences, Inc. Common Stock reported EPS of -$0.02, beating estimates by 96.25%, and revenue of $83.04M, 14.33% above expectations.
How did the market react to Castle Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 21.7%, changed from $25.99 before the earnings release to $31.63 the day after.
When is Castle Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Castle Biosciences, Inc. Common Stock's next earnings report?
Based on 10
analysts, Castle Biosciences, Inc. Common Stock is expected to report EPS of -$0.31 and revenue of $78.64M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement